Back to Search Start Over

Inhibition of Mycobacterium tuberculosis Dethiobiotin Synthase ( Mt DTBS): Toward Next-Generation Antituberculosis Agents.

Authors :
Schumann NC
Lee KJ
Thompson AP
Salaemae W
Pederick JL
Avery T
Gaiser BI
Hodgkinson-Bean J
Booker GW
Polyak SW
Bruning JB
Wegener KL
Abell AD
Source :
ACS chemical biology [ACS Chem Biol] 2021 Nov 19; Vol. 16 (11), pp. 2339-2347. Date of Electronic Publication: 2021 Sep 17.
Publication Year :
2021

Abstract

Mycobacterium tuberculosis dethiobiotin synthase ( Mt DTBS) is a crucial enzyme involved in the biosynthesis of biotin in the causative agent of tuberculosis, M. tuberculosis . Here, we report a binder of Mt DTBS, cyclopentylacetic acid 2 ( K <subscript>D</subscript> = 3.4 ± 0.4 mM), identified via in silico screening. X-ray crystallography showed that 2 binds in the 7,8-diaminopelargonic acid (DAPA) pocket of Mt DTBS. Appending an acidic group to the para-position of the aromatic ring of the scaffold revealed compounds 4c and 4d as more potent binders, with K <subscript>D</subscript> = 19 ± 5 and 17 ± 1 μM, respectively. Further optimization identified tetrazole 7a as a particularly potent binder ( K <subscript>D</subscript> = 57 ± 5 nM) and inhibitor ( K <subscript>i</subscript> = 5 ± 1 μM) of Mt DTBS. Our findings highlight the first reported inhibitors of Mt DTBS and serve as a platform for the further development of potent inhibitors and novel therapeutics for the treatment of tuberculosis.

Details

Language :
English
ISSN :
1554-8937
Volume :
16
Issue :
11
Database :
MEDLINE
Journal :
ACS chemical biology
Publication Type :
Academic Journal
Accession number :
34533923
Full Text :
https://doi.org/10.1021/acschembio.1c00491